HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Tuberous sclerosis syndrome — Clinical Guidelines

Overview

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the development of hamartomas across multiple organ systems, including the brain, kidneys, skin, heart, and lungs, due to mutations in TSC1 or TSC2 genes leading to hyperactivation of the mTOR pathway 1 3.

Diagnosis

Clinical Criteria: Presence of major features (e.g., facial angiofibromas, renal angiomyolipomas, cortical tubers) or minor features (e.g., multiple retinal hamartomas, subependymal giant cell astrocytoma) 1 12.

Genetic Testing: Identification of pathogenic variants in TSC1 or TSC2 genes 1 12.

Imaging: MRI for brain lesions, ultrasound or CT for renal involvement, and chest imaging for pulmonary manifestations 1 11.

Multidisciplinary Approach: Diagnosis often requires input from neurology, nephrology, dermatology, and radiology 1 3.

Management

First-Line Treatments:

- mTOR Inhibitors: Everolimus and Sirolimus for reducing tumor growth and managing seizures, subependymal giant cell astrocytomas, and angiomyolipomas 2 12.

Adjunctive Treatments:

- Seizure Control: Antiepileptic drugs tailored to individual seizure types 1 12. - Behavioral and Cognitive Support: Early intervention programs for cognitive and behavioral issues 1 12. - Renal Surveillance: Regular imaging to monitor renal angiomyolipomas for potential complications 1 3.

Special Populations

Pediatrics: Early diagnosis and multidisciplinary care crucial; genetic testing and neuroimaging essential 10 15.

Comorbidities:

- Endocrine Disorders: Monitor for hypothyroidism and precocious puberty 13. - Cardiac Involvement: Regular cardiac evaluations for arrhythmias and rhabdomyomas 16 23.

Key Recommendations

Utilize genetic testing to confirm TSC diagnosis in patients with characteristic clinical features 1 12 (Evidence: Strong).

Consider mTOR inhibitors for managing tumor growth and associated complications in TSC patients 2 12 (Evidence: Moderate).

Implement multidisciplinary surveillance and management strategies involving neurology, nephrology, and dermatology 1 3 (Evidence: Expert opinion).

References

1 Robichaud JH, Afrin H, Torres VE, Gupta NR. Clinical Management of Tuberous Sclerosis: A Nephrologist's Perspective. Kidney360 2025. link 2 Liu M, Ye J, You X. An updated meta-analysis of effectiveness and safety of mTOR inhibitors in the management of tuberous sclerosis complex patients. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2024. link 3 Monich AG, Bissler JJ, Barreto FC. Tuberous Sclerosis Complex and the kidneys: what nephrologists need to know. Jornal brasileiro de nefrologia 2024. link 4 Ihrie RA, Henske EP. Modeling tuberous sclerosis with organoids. Science (New York, N.Y.) 2022. link 5 . Neural Progenitors Promote Malformations in Tuberous Sclerosis Complex. Cancer discovery 2022. link 6 Amphornphruet A, Chotcomwongse P, Yimrattananuwat K, Ferrone P. Spontaneous Resolution of Subretinal Fluid Secondary to Retinal Astrocytic Hamartoma in Tuberous Sclerosis:A Case Report. Ophthalmic surgery, lasers & imaging retina 2019. link 7 Jacks SK, Witman PM. Tuberous Sclerosis Complex: An Update for Dermatologists. Pediatric dermatology 2015. link 8 Back SJ, Andronikou S, Kilborn T, Kaplan BS, Darge K. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome. Pediatric radiology 2015. link 9 Incedayi M, Sonmez G, Basekim C. Massive bilateral renal angiomyolipomatosis and multifocal micronodular pneumocytes hyperplasia associated with tuberous sclerosis: a case report. Wiener klinische Wochenschrift 2011. link 10 Datta AN, Hahn CD, Sahin M. Clinical presentation and diagnosis of tuberous sclerosis complex in infancy. Journal of child neurology 2008. link 11 Umeoka S, Koyama T, Miki Y, Akai M, Tsutsui K, Togashi K. Pictorial review of tuberous sclerosis in various organs. Radiographics : a review publication of the Radiological Society of North America, Inc 2008. link 12 Schwartz RA, Fernández G, Kotulska K, Jóźwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. Journal of the American Academy of Dermatology 2007. link 13 Adhvaryu K, Shanbag P, Vaidya M. Tuberous sclerosis with hypothyroidism and precocious puberty. Indian journal of pediatrics 2004. link 14 Warner JE, Lessell S. Cataract in tuberous sclerosis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 1997. link 15 Blossom HJ. Tuberous sclerosis in early infancy: a case report. The Journal of family practice 1993. link 16 Raut NB, Norton JB, Patil AA. Bourneville's tuberous sclerosis associated with double outlet right ventricle and infundibular pulmonary stenosis. The Journal of the Association of Physicians of India 1992. link 17 Clarke DJ, Buckley ME, Burns BH. Epilepsy and psychosis--ask the family. The British journal of psychiatry : the journal of mental science 1987. link 18 Mandia SE, Dolan EP, Roach JP. Spontaneous intraperitoneal rupture of a kidney in a patient with tuberous sclerosis. The Journal of urology 1986. link44737-9) 19 Liberman BA, Chamberlain DW, Goldstein RS. Tuberous sclerosis with pulmonary involvement. Canadian Medical Association journal 1984. link 20 Waga S, Yamamoto Y, Kojima T, Sakakura M. Massive hemorrhage in tumor of tuberous sclerosis. Surgical neurology 1977. link 21 Scully C. Orofacial manifestations in tuberous sclerosis. Oral surgery, oral medicine, and oral pathology 1977. link90380-2) 22 Earhart RN, Nuss DD, Martin RJ, Imber R, Aeling JL. Dermabrasion for adenoma sebaceum. The Journal of dermatologic surgery 1976. link 23 Cosnett JE, Gibb BH. Tuberous sclerosis and cardiac arrhythmia in three Zulu patients. British medical journal 1969. link

Tuberous sclerosis syndrome